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STUDY BRIEF

Uganda Retail Audit
Analysis and Report

The Total Market Approach (TMA) leverages the
comparative advantages of all market sectors to enhance
equitable and sustainable family planning (FP) across
market segments, with government coordination and
support. It is based on an understanding that equitably
meeting the diverse needs of different population
segments requires increased coordination across
sectors, including the public, private for-profit, and
not-for-profit sectors. This is particularly important in
the context of global commitments to increase access
to family planning, including the FP2020 goal of
reaching 120 million additional women by 2020.

ages 15 to 49, and 32.2% for married women. The
PMA 2020 report found that injectables are the most
popular method, used by more than half of married
contraceptive users. See Figure 1 for a breakdown of
Uganda’s method mix.
F IGURE 1 . C URRENT MO D ERN METH O D MIX
A MO NG MA RRIED C O NTRAC EPTIVE USERS

According to the 2016 Performance Monitoring and
Accountability (PMA) 2020 Detailed Indicator Report,
the modern contraceptive prevalence rate (mCPR)
in Uganda is 27.5% for all sexually active women,
mCPR: 32.2%
Unmet Need: 30.5%

Study Design
This brief is based on a retail audit, carried
out in January 2016, that was commissioned
as part of PATH’s work under the USAIDfunded Evidence Project to conduct a landscape
assessment of the feasibility of a Total Market
Approach in Uganda. This project also involved
key informant interviews with stakeholders on
their attitudes towards TMA principles and the
collection of a Uganda Market Research Summary
of existing FP knowledge. In the retail audit,
stratified random sampling was used to select
outlets for evaluation from a sampling frame of
187,580 outlets, consisting of health facilities,
pharmacies, drug shops, and village health teams
(VHTs). The sample was split across regions,
based on the percentage of total outlets in each
region. Kampala was treated as a separate region,
since it has a disproportionately high number of
outlets (27% of the total number of outlets in
Uganda). Districts were randomly selected from
within each region, and outlets were randomly
selected to meet the quota per district and quota
per region. A total representative sample of
664 outlets was identified, distributed across
the regions as follows: Kampala (27%), Central
(16%), Northern (15%), Eastern (20%), and
Western (22%). Data was collected on:
▪▪ Percentage of outlets that report having
stock of or selling contraceptive methods.
(Note: data was collected separately for contraceptive
methods stocked and contraceptive methods sold, so
these measures are reported separately here.)
▪▪ Product demand, according to outlet
managers.
▪▪ Most frequently cited factors affecting
client’s purchase of contraceptive products,
according to outlet managers.
▪▪ Most common retail price points for
contraceptive products.
▪▪ Percentage of outlet managers reporting a
stock out (among outlets that responded to
the question regarding stock outs).
▪▪ Distribution of stock out times.
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Percent of facilities offering
contraceptive products
The Ugandan public health system is divided into five
different levels encompassing national and district levels
(see Box 1). The retail audit collected and analyzed data
from facilities at each level.
The methods stocked or sold by the highest number
of facilities were male condoms, combined oral
contraceptive pills, and progesterone-only injectables.
Although this pattern was similar across nearly all
facilities, the percent of facilities stocking or selling
each method differed by facility type. Ninety percent of
all facilities stocked or sold male condoms, though this
ranged from 74% (Health Center II facilities) to 93%
(drug shops). The percentage of all facilities that stocked
or sold pills was 63%, with a range of 23% (VHTs /
Health Centre I) to 87% (registered pharmacies). Nearly
half (49%) of all facilities stocked or sold progesteroneonly injectables, with a range of 27% (VHTs / Health
Center I) to 74% (Health Centre II). Levonorgestrel
IUDs were the least likely method to be stocked or sold
by any facility, across all categories (stocked or sold by
less than 1% of all facilities).

BOX 1

LEVELS OF UGANDAN HEALTH
FACILITIES
The lowest rung is made up of Village Health
Teams (VHTs, also referred to as Health Centre
I). Health Centre II is the second-lowest level,
comprising outpatient services provided by
nurses. Health Centre IIIs offer additional services, including in-patient and maternal health
treatment. Health Centre IVs are staffed by
medical doctors and offer a variety of in- and
out-patient services. Finally, public hospitals
are considered the highest level and are divided into three groups: general hospitals, regional referral hospitals, and national referral hospitals. Regional and national referral hospitals
have been combined into one group for the purposes of data analysis, while private hospitals
are aggregated with general hospitals.

the method. For example, VHTs often provide health
services to rural villages and areas that have limited
storage or transportation capacity, and male condoms
are the most frequently stocked or sold product at
this level, with the next most common commodities
(injectables and pills) stocked or sold by only around
one quarter of VHTs. And a high percentage of
registered pharmacies stocked or sold male condoms,
combined pills, and emergency contraception, but very
few of these facilities stocked or sold IUDs or implants,
which require trained providers and additional medical
supplies that pharmacies are less likely to have.

Referral hospitals showed a slightly different pattern:
male condoms were the most commonly stocked
or sold method among these facilities, but this was
followed by implants and copper IUDs (both of which
were stocked or sold by fewer outlets in other facility
categories). Registered pharmacies also deviated from
the overall trend, with emergency contraception being
the third most commonly stocked or sold method at
facilities in this category.
The proportion of facilities stocking and selling
particular methods is often tied to characteristics of

FIGURE 1 | PERCENT OF HEALTH CENTRE FACILITIES REPORTING STOCK OR SALES OF CONTRACEPTIVE PRODUCTS
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FIGURE 2 | PERCENT OF PRIVATE RETAILERS REPORTING STOCK OR SALES OF CONTRACEPTIVE PRODUCTS
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Most frequently cited factor
affecting purchase
The factors that outlet managers think influence
their clients’ choice of contraceptive method may
consequently influence what outlet managers then
decide to stock. Facility managers were asked “what
do you think is the most frequently cited factor that
influences the purchase of a contraceptive method?”
In general, avoidance of perceived side effects was the
most commonly cited factor, with knowledge/familiarity
with the brand and the low price of the product cited
slightly less commonly. Duration of the method, brand
visibility, and “promotion” of the brand (i.e. whether it
is on sale) were the least frequently mentioned.
With managers responding that neither the low price of
the brand nor its perceived quality have much influence
on clients’ purchase decisions, commercial sector
managers could market their products more effectively
by considering clients’ concerns about side effects and
levels of knowledge or familiarity with the product,
the two most influential factors (e.g. emphasizing that
a certain type of injectable is known to have fewer
side effects). In addition, the relatively high percentage
for access and availability for implants suggests that
the need for administration by a trained provider is a
barrier to use.

Analysis of retail price points
Mapping the range of price points for different
contraceptive methods, including products that are
available for free or at an artificially low cost, allows
TMA planners to know which sectors are the primary
providers of specific methods and to set appropriate
price points. Identifying the most common price points
for different contraceptive methods allows TMA
planners to help outlet managers know where to set
their prices to remain viable. Noting the presence of
free or artificially low price points helps to identify
which products come from the public or social
marketing sectors.
219 facilities sold social marketing agency-branded
condoms; these condoms (available in packs of three)
were most commonly sold for 1,000, 2,000, and 3,000
UGX (US$0.30 to $1.00), although the fourth most
common price point was 0 UGX. Since social marketing
products are typically sold for a (often low) fee, the
availability of these condoms for free suggests that
retail outlets may have obtained these products from
a third-party outlet, rather than directly from the social
marketing agency. Fewer facilities sold non-subsidized,
commercial condom brands (18 facilities sold Durex, 57
facilities sold Contempo), with greater price variation
(1,000 to 82,500 UGX for a three-pack of Contempo
condoms and 1,000 to 15,000
UGX for Durex condoms).
Of 401 facilities that carry
combined oral contraceptives
(COC), 31% provide them
for free, which indicates the
significant influence in the
Ugandan market of the free
provision of
contraceptives
by the public sector and the
government. Among consumers
who pay for COCs, 1,000 UGX
($0.30) is the most common price.
Progesterone-only pills (sold by
44 facilities) follow a similar trend
with free, presumably public
sector-provided product being
most common and 1,000 UGX
and 3,000 UGX being the top two
most frequently charged prices.
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Of the 59 facilities that carry implants, 371 facilities that
carry injectables, and 89 facilities that carry IUDs, the
majority offer these commodities for free (66%, 50%,
and 55% respectively). When not free, prices charged
for these methods vary greatly: implants range from
1,000 to 100,000 UGX (with no price most common);
injectables were most often priced at 2,000 (8%), 3,000
(5%), and 1,000 (5%) UGX; and IUDs - typically the
most expensive of the three – most often cost 20,000
UGX (US$5.90) and 10,000 UGX (US$3.00). That a
majority of these facilities offer these commodities for
free suggests that the public sector is the primary source
for implants, IUDs, and injectable products and services.
Emergency contraception is available at a wide range of
prices, but the most common price is overwhelmingly
10,000 UGX (approximately US$3.00). Emergency
contraception is also widely available for free; the fact
that free was not the most common price (as it is for
implants, pills, injectables, and IUDS) may be due to the
fact that it is a more expensive product and is thus not
purchased at as high a rate by the public sector as other
products. In addition, many users do not plan in advance
to use emergency contraception and may therefore be
more willing to pay to obtain it quickly, feeling that the
extra time required to get it for free isn’t worth it.
The preponderance of contraceptive
products being distributed for free,
especially pills and injectables, indicates
the extent to which public sectorprovided commodities dominate the
market in Uganda. A next step would
be to conduct market segmentation and
willingness/ability to pay studies to more
accurately determine the characteristics
of clients accessing these products.
However, the sheer amount of free
product being distributed means that
some users will inevitably use these free
methods, even if they have the means
to purchase the product. This points
to the need to encourage eligible users
to move up the value chain to products
they are willing and able to pay for and
leave the free product to users without
the means to pay for contraception.

1

Stockouts
Outlet managers were asked about each brand of
each type of contraceptive method and whether they
were experiencing a stockout at their facility. Among
facilities that responded, one or more brands of pills,
male condoms, and emergency contraception were
out of stock. Stockouts seem to be most prevalent for
products for which there are multiple brands, such as
pills and condoms. There are not typically many brands
of emergency contraception, and the high percentage
of stockouts for that method may be because facilities
carry small amounts due to low demand (emergency
contraception is used by only 0.3% of contraceptive
users in Uganda). Of the facilities reporting stockouts,
the majority of stockouts of injectables, emergency
contraception, pills, and male condom brands lasted
less than 30 days.
The fact that there is a high rate of stockouts among the
most popular methods, and that those stockouts can
sometimes continue for months at a time, is a concerning
sign regarding the strength of the contraceptive supply
chain. Reducing the amount of stockouts that occur,
as well as speeding up the rate of re-delivery, are two
central areas where increased government stewardship
could play a role.

FIGURE 3 | PRODUCTS THAT WERE OUT OF STOCK IN FACILITIES THAT
HAD REPORTED A STOCKOUT 1
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Stockout is defined here as having a quantity of zero of the brand of product on the day the survey was conducted
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